Congo vs United Kingdom of Great Britain and Northern Ireland: Treatment success rate for patients treated for MDR-TB

Congo
83.0%
in 2022
United Kingdom of Great Britain and Northern Ireland
83.0%
in 2022
Congo rank
42nd
United Kingdom of Great Britain and Northern Ireland rank
42nd

Treatment success rate for patients treated for MDR-TB over time

  • Congo
  • United Kingdom of Great Britain and Northern Ireland
20406080200220122022

How they compare

Congo currently reports 83.0% against 83.0% in United Kingdom of Great Britain and Northern Ireland, a difference of 0.0%.

The two have swapped places 2 times across 7 shared years of data; in 2015 it was United Kingdom of Great Britain and Northern Ireland ahead.

Congo ranks 42nd and United Kingdom of Great Britain and Northern Ireland ranks 42nd of 163 countries.

Across the 2 decades both report, Congo averaged higher in 1 and United Kingdom of Great Britain and Northern Ireland in 1.

Head to head by decade

Decade Congo United Kingdom of Great Britain and Northern Ireland Difference Ahead
2010s 78.0% 68.8% 9.2% Congo
2020s 71.7% 81.3% 9.7% United Kingdom of Great Britain and Northern Ireland

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment success rate for patients treated for mdr-tb, Congo or United Kingdom of Great Britain and Northern Ireland?
Congo, at 83.0% against 83.0% in United Kingdom of Great Britain and Northern Ireland as of 2022.
What is the difference in treatment success rate for patients treated for mdr-tb between Congo and United Kingdom of Great Britain and Northern Ireland?
0.0%, with Congo ahead.
How many years of comparable data are there for Congo and United Kingdom of Great Britain and Northern Ireland?
7 years are reported by both, from 2015 to 2022.
How do Congo and United Kingdom of Great Britain and Northern Ireland rank globally for treatment success rate for patients treated for mdr-tb?
Congo ranks 42nd and United Kingdom of Great Britain and Northern Ireland ranks 42nd of 163 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Congo vs United Kingdom of Great Britain and Northern Ireland: Treatment success rate for patients treated for MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 13 September 2026, from https://health.statizoid.com/compare/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/congo-rep/united-kingdom/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/congo-rep/united-kingdom/">Congo vs United Kingdom of Great Britain and Northern Ireland: Treatment success rate for patients treated for MDR-TB</a> — Statizoid

About this data

Indicator
Treatment success rate for patients treated for MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
175 places, 2,495 data points, 1999–2022
Last refreshed